115 related articles for article (PubMed ID: 29414834)
21. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
Kuhlmann MK
Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819
[TBL] [Abstract][Full Text] [Related]
22. [Phosphate kinetics in patients on chronic hemodialysis].
Okuda N; Kuno T; Nagura Y; Kanmatsuse K
Nihon Jinzo Gakkai Shi; 2000 Jan; 42(1):30-5. PubMed ID: 10737011
[TBL] [Abstract][Full Text] [Related]
23. Modifications to bicarbonate conductivity: A way to increase phosphate removal during hemodialysis? Proof of concept.
Bertocchio JP; Mohajer M; Gaha K; Ramont L; Maheut H; Rieu P
Hemodial Int; 2016 Oct; 20(4):601-609. PubMed ID: 27060343
[TBL] [Abstract][Full Text] [Related]
24. Peritoneal phosphate removal varies by peritoneal dialysis regimen: an underestimated parameter of phosphate control.
Botelho C; Rodrigues A; Oliveira JC; Cabrita A
J Nephrol; 2013; 26(1):183-90. PubMed ID: 22460184
[TBL] [Abstract][Full Text] [Related]
25. Enhanced solute removal with intermittent, in-center, 8-hour nocturnal hemodialysis.
Troidle L; Finkelstein F; Hotchkiss M; Leypoldt JK
Hemodial Int; 2009 Oct; 13(4):487-91. PubMed ID: 19840141
[TBL] [Abstract][Full Text] [Related]
26. Improvements in phosphate control with short daily in-center hemodialysis.
Yuen D; Richardson RM; Chan CT
Clin Nephrol; 2005 Nov; 64(5):364-70. PubMed ID: 16312264
[TBL] [Abstract][Full Text] [Related]
27. Effect of cool vs. warm dialysate on toxin removal: rationale and study design.
Maheshwari V; Lau T; Samavedham L; Rangaiah GP
BMC Nephrol; 2015 Feb; 16():25. PubMed ID: 25885180
[TBL] [Abstract][Full Text] [Related]
28. Acute hemodynamic response and uremic toxin removal in conventional and extended hemodialysis and hemodiafiltration: a randomized crossover study.
Cornelis T; van der Sande FM; Eloot S; Cardinaels E; Bekers O; Damoiseaux J; Leunissen KM; Kooman JP
Am J Kidney Dis; 2014 Aug; 64(2):247-56. PubMed ID: 24698199
[TBL] [Abstract][Full Text] [Related]
29. Time and exercise improve phosphate removal in hemodialysis patients.
Vaithilingam I; Polkinghorne KR; Atkins RC; Kerr PG
Am J Kidney Dis; 2004 Jan; 43(1):85-9. PubMed ID: 14712431
[TBL] [Abstract][Full Text] [Related]
30. Phosphate and Calcium Control in Short Frequent Hemodialysis with the NxStage System One Cycler: Mass Balance Studies and Comparison with Standard Thrice-Weekly Bicarbonate Dialysis.
Brunati CCM; Gervasi F; Casati C; Querques ML; Montoli A; Colussi G
Blood Purif; 2018; 45(4):334-342. PubMed ID: 29455202
[TBL] [Abstract][Full Text] [Related]
31. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
[TBL] [Abstract][Full Text] [Related]
32. Association between phosphate removal and markers of bone turnover in haemodialysis patients.
Albalate M; de la Piedra C; Fernández C; Lefort M; Santana H; Hernando P; Hernández J; Caramelo C
Nephrol Dial Transplant; 2006 Jun; 21(6):1626-32. PubMed ID: 16490746
[TBL] [Abstract][Full Text] [Related]
33. Phosphate removal and hemodialysis conditions.
Pohlmeier R; Vienken J
Kidney Int Suppl; 2001 Feb; 78():S190-4. PubMed ID: 11169009
[TBL] [Abstract][Full Text] [Related]
34. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis.
Mucsi I; Hercz G; Uldall R; Ouwendyk M; Francoeur R; Pierratos A
Kidney Int; 1998 May; 53(5):1399-404. PubMed ID: 9573558
[TBL] [Abstract][Full Text] [Related]
35. Lack of significant circadian and post-prandial variation in phosphate levels in subjects receiving chronic hemodialysis therapy.
Trivedi H; Moore H; Atalla J
J Nephrol; 2005; 18(4):417-22. PubMed ID: 16245246
[TBL] [Abstract][Full Text] [Related]
36. [The impact of changes in levels of calcium, phosphate and magnesium during hemodialysis on autonomic system reactivity as measured by heart rate variability analysis].
Buda S; Stompór T; Sułowicz W; Kopeć J; Szymczakiewicz-Multanowska A; Janion M
Przegl Lek; 2000; 57(6):340-5. PubMed ID: 11107869
[TBL] [Abstract][Full Text] [Related]
37. Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.
Evenepoel P; Bammens B; Verbeke K; Vanrenterghem Y
Kidney Int; 2006 Aug; 70(4):794-9. PubMed ID: 16820785
[TBL] [Abstract][Full Text] [Related]
38. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
[TBL] [Abstract][Full Text] [Related]
39. Protein-bound solute removal during extended multipass versus standard hemodialysis.
Eloot S; Van Biesen W; Axelsen M; Glorieux G; Pedersen RS; Heaf JG
BMC Nephrol; 2015 Apr; 16():57. PubMed ID: 25896788
[TBL] [Abstract][Full Text] [Related]
40. Bioimpedance and the duration of the hemodialysis session.
Basile C; Libutti P; Di Turo AL; Casucci F; Losurdo N; Teutonico A; Vernaglione L; Lomonte C
ASAIO J; 2011; 57(4):310-3. PubMed ID: 21646906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
